Associated expression of HLA class I and class II antigens on melanoma cells in surgically removed metastases
β Scribed by S. G. Van Duinen; D. I. Ruiter; S. Ferrone
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 717 KB
- Volume
- 149
- Category
- Article
- ISSN
- 0022-3417
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
HLA class-I expression has been investigated by biochemical methods in 14 Burkitt lymphoma (BL) cell lines and the corresponding Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) derived from the same individuals. Selective down-regulation of one or more HLA class-I specificities
Expression of the major histocompatibility (MHC) class I and class H antigens was studied by immunohistochemistry in a series of 70 primary breast carcinomas and in nodal metastases. In particular, the expression of class I (HLA A-B-C) and class II (DP, DQ and DR) molecules was compared in: a) prima
## Abstract Alterations in the surface expression of HLA class I molecules have been described as a strategy of tumors to evade recognition by cytotoxic T cells. We detected complete loss of HLA class I antigen presentation for 2 tumor cell lines from 1 melanoma patient, the first originated from a
Tumor necrosis factor (TNF-a) was compared to immune interferon (IFNq) for its ability to modulate the expression and shedding of HLA antigens, of intercellular adhesion molecule l (ICAM l) and of high-molecular-weight melanomaassociated antigen (HMW MAA) by a panel of melanoma cell lines. The latte